SCHEMBL5060760

SCHEMBL5060760

NC(=S)Nc1cccc(OCCCCCCCN2CCN(c3ccc(F)cc3)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.60
SLC6A4 P31645 2/20 0.60
ALOX15 P16050 1/20 0.55
EPHX2 P34913 5/20 0.54
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
HTR1A P08908 4/20 0.52
DRD2 P14416 3/20 0.52
HTR2A P28223 3/20 0.52
DRD3 P35462 2/20 0.52
HRH1 P35367 1/20 0.52
TMEM97 Q5BJF2 1/20 0.52
SIGMAR1 Q99720 1/20 0.52
ALDH1A1 P00352 1/20 0.51
ABCB1 P08183 2/20 0.51
DRD1 P21728 1/20 0.50
DRD5 P21918 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4338849 1.00 SLC6A2 (0.60) SLC6A2SLC6A4ALOX15EPHX2POLB
SCHEMBL5053711 1.00 SLC6A2 (0.60) SLC6A2SLC6A4ALOX15EPHX2POLB
SCHEMBL5060790 1.00 SLC6A2 (0.60) SLC6A2SLC6A4ALOX15EPHX2POLB
SCHEMBL5053732 0.99 SLC6A2 (0.61) SLC6A2SLC6A4ALOX15EPHX2POLB
SCHEMBL5053698 0.96 EPHX2 (0.58) SLC6A2SLC6A4ALOX15EPHX2POLB
SCHEMBL5053658 0.92 HTR1A (0.56) SLC6A2SLC6A4EPHX2MAPTMAPK1
SCHEMBL5060794 0.92 HTR1A (0.56) SLC6A2SLC6A4EPHX2MAPTMAPK1
SCHEMBL5053727 0.92 HTR1A (0.56) SLC6A2SLC6A4EPHX2MAPTMAPK1
SCHEMBL5053729 0.92 HTR1A (0.56) SLC6A2SLC6A4EPHX2MAPTMAPK1
SCHEMBL12797500 0.91 DRD2 (0.52) SLC6A2SLC6A4ALOX15EPHX2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897764-B2 Thiourea derivatives NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-03-01 US disclosed
US-7897764-B2 Thiourea derivatives NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-03-01 US disclosed
US-20080306090-A1 THIOUREA DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-12-11 US disclosed
US-20080306090-A1 THIOUREA DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306090-A1 THIOUREA DERIVATIVES EIF2AK2, IFNAR1, TPMT SLC6A2 2714/4885SLC6A4 2442/4885ALOX15 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.